SHWZ — Medicine Man Technologies Share Price
0.000.00%
Last trade - 00:00- $52.66m
- $189.76m
- $172.45m
- 29
- 80
- 69
- 61
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.44 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 33.22 | ||
| Price to Sales | 0.31 | ||
| EV to EBITDA | 8.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.44% | ||
| Return on Equity | -33.97% | ||
| Operating Margin | 0.77% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 12.4 | 24 | 108.42 | 159.38 | 172.45 | 174.47 | 192.45 | 78.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Company’s business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Company’s general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 20th, 2014
- Public Since
- December 23rd, 2015
- No. of Shareholders
- 122
- No. of Employees
- 729
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 77,438,379
- Address
- 865 N. Albion St., Suite 300, DENVER, 80220
- Web
- http://medicinemantechnologies.com/
- Phone
- +1 3033710387
- Auditors
- BF Borgers CPA PC
Upcoming Events for SHWZ
Medicine Man Technologies Inc Annual Shareholders Meeting
Q2 2024 Medicine Man Technologies Inc Earnings Release
Similar to SHWZ
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
FAQ
What is the Medicine Man Technologies share price?
As of Today at 19:14 UTC, shares in Medicine Man Technologies are trading at $0.68. This share price information is delayed by 15 minutes.
How has the Medicine Man Technologies share price performed this year?
Shares in Medicine Man Technologies last closed at $0.68 and the price had moved by -38.18% over the past 365 days. In terms of relative price strength the Medicine Man Technologies share price has underperformed the S&P500 Index by -45.46% over the past year.
What are the analyst and broker recommendations for Medicine Man Technologies?
The overall consensus recommendation for Medicine Man Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medicine Man Technologies dividend yield?
Medicine Man Technologies does not currently pay a dividend.
Does Medicine Man Technologies pay a dividend?
Medicine Man Technologies does not currently pay a dividend.
When does Medicine Man Technologies next pay dividends?
Medicine Man Technologies does not currently pay a dividend.
How do I buy Medicine Man Technologies shares?
To buy shares in Medicine Man Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medicine Man Technologies?
As of the previous close price of $0.68, shares in Medicine Man Technologies had a market capitalisation of $52.66m.
Where are Medicine Man Technologies shares listed?
Here are the trading details for Medicine Man Technologies:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SHWZ
What kind of share is Medicine Man Technologies?
Based on an overall assessment of its quality, value and momentum Medicine Man Technologies is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medicine Man Technologies share price forecast for 2024?
The analyst consensus target price for shares in Medicine Man Technologies is $2.83. That is 316.18% above the last closing price of $0.68.
Analysts covering Medicine Man Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$0.47 for the next financial year.
What is the trend in the Medicine Man Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medicine Man Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -12.53%.
As of the last closing price of $0.68, shares in Medicine Man Technologies were trading -17.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medicine Man Technologies PE Ratio?
The Medicine Man Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medicine Man Technologies?
We do not have data on Medicine Man Technologies' directors